Published 20:21 IST, June 11th 2024

US FDA Advisory Committee Unanimously Backs Eli Lilly's Alzheimer's Drug

The Alzheimer's drug 'donanemab' by Eli Lily received approval from the US Food and Drug Administration's committee of independent advisors.

Follow: Google News Icon
  • share
Representative Photo
Representative Photo | Image: Freepik
  • Listen to this article
  • 2 min read

20:21 IST, June 11th 2024